Siga Technologies (SIGA) Deferred Taxes (2010 - 2025)
Siga Technologies' (SIGA) quarterly Deferred Taxes came in at $2.4 million in Q3 2025, up 588.34% on a YoY basis from $349643.9 in Q3 2024, and down 66.41% quarter-over-quarter from $7.2 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Deferred Taxes (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Deferred Taxes for 16 consecutive years, with $2.4 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Deferred Taxes rose 588.34% year-over-year to $2.4 million; the trailing twelve-month figure through Sep 2025 stood at $10.6 million (up 353.02% YoY), and the FY2024 full-year result was $294028.0, up 106.13% from the prior year.
- Deferred Taxes fell to $2.4 million in Q3 2025 per SIGA's latest filing, from $7.2 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $7.2 million in Q2 2025 and bottomed at -$3.2 million in Q4 2023.
- Historically, Deferred Taxes has averaged $57063.8 across 5 years, with a median of -$277850.0 in 2025.
- The sharpest annual moves came in 2022 and 2025: Deferred Taxes sank 5549.89% in 2022, then soared 1293.71% in 2025.
- Over 5 years, Deferred Taxes stood at $529679.0 in 2021, then sank by 490.14% to -$2.1 million in 2022, then tumbled by 52.46% to -$3.2 million in 2023, then surged by 142.87% to $1.4 million in 2024, then jumped by 78.19% to $2.4 million in 2025.
- According to Business Quant data, Deferred Taxes over the past three periods registered $2.4 million, $7.2 million, and -$277850.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -479.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -195.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -544.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1.32 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 115.62 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 25.70 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 7.17 Mn |
| Mar 31, 2025 | -277,850.00 |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | -492,840.00 |
| Jun 30, 2024 | -600,257.00 |
| Mar 31, 2024 | 36,450.00 |
| Dec 31, 2023 | -3.15 Mn |
| Sep 30, 2023 | -305,833.00 |
| Jun 30, 2023 | -857,933.00 |
| Mar 31, 2023 | -483,425.00 |
| Dec 31, 2022 | -2.07 Mn |
| Sep 30, 2022 | -1.14 Mn |
| Jun 30, 2022 | 995,327.00 |
| Mar 31, 2022 | -1.61 Mn |
| Dec 31, 2021 | 529,679.00 |
| Sep 30, 2021 | -220,813.00 |
| Jun 30, 2021 | -158,879.00 |
| Mar 31, 2021 | -28,541.00 |
| Dec 31, 2020 | 3.94 Mn |